[LONE TREE, CO, July 8, 2025]: Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of the Cochlear™ […]
Written by Guest Author, Dr. Abby Meyer, MD, MPH, FAAP Congenital cytomegalovirus (cCMV) infection is the most common congenital infection with an estimated prevalence of approximately 1 in 200 births. […]
[LONE TREE, CO] – June 2, 2025: Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announces today the commercial release of the new Cochlear™ Baha® 7 Sound […]
Cochlear™ Nucleus® Implant electrode array design is a widely debated topic when it comes to performance and patient outcomes. This Science Spotlight focuses on a study out of Columbia University […]
As we reflect on the past quarter, I am filled with immense pride and gratitude for the remarkable achievements and milestones our community has made. This year marks the 5th […]
Co-authored by Alejandra Ullauri, Au.D, MPH, ABA-CISD. It is well documented that hearing loss makes it more difficult for patients to communicate with their healthcare provider¹. This is complicated even […]
The purpose of this article is to provide professionals with: We take pride in building strong relationships with our customers, ensuring they are seen, heard, and feel valued. We recognize […]
Join Cochlear at the American Academy of Audiology 2025 Conference in New Orleans from March 26th – 29th! Don’t miss this opportunity to connect with leading experts, explore groundbreaking technologies […]
This last year, we launched Beyond the Decibels, our podcast dedicated to exploring the latest advancements, stories, and insights in the world of hearing care, and we believe you’ll find it […]
Pitch matching between ears is an important aspect of our auditory system, enhancing our ability to interact with and interpret our environment effectively.¹ In the realm of cochlear implants, this […]
End of content
No more pages to load
